Laddar...
Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine
Sickle cell anemia (SCA) is a common and devastating inherited blood disorder, affecting millions of people across the world. Without treatment, SCA results in tremendous morbidity and early mortality. Hydroxyurea is the primary and most well-established pharmacologic therapy with proven benefits to...
Sparad:
| I publikationen: | Clin Pharmacol Ther |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902468/ https://ncbi.nlm.nih.gov/pubmed/32869281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2028 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|